← Back
Clinical Pathophysiology I · Exam 2 · Class of 2028

Clinical Pathophysiology I Exam 2 Cram Sheet

Lectures 6 Cardiac, 7 Vascular, 8 Immunity, 9 Pulmonary and 10 Blood Disorders, condensed. ★ = the lecturer said to know it. Mechanism only, never management.

How to use this: this is a condensed, night-before-the-exam reference, not a replacement for the full study guide — it assumes you've already learned the material and just need the highest-yield facts at a glance. If a term feels unfamiliar, go back to the full guide for the explanation.

L6 · Coronary Heart Disease & Ischemia

TermWhat you need to know
Coronary heart diseaseInsufficient delivery of oxygenated blood to the myocardium because of ATHEROSCLEROTIC coronary arteries. About 50% of cardiovascular deaths. Also called ischemic heart disease, coronary artery disease.
Ischemia = supply vs demandBegins when oxygen SUPPLY < DEMAND → less ATP (adenosine triphosphate). Causes abnormal function AND abnormal rhythms; prolonged → irreversible damage.
Supply fallsLarge plaques · acute platelet aggregation then thrombosis · VASOSPASM · abnormal microcirculation · poor perfusion pressure.
Demand risesWorkload = HEART RATE · PRELOAD · AFTERLOAD · CONTRACTILITY. Raise any one → more oxygen demand.
EtiologiesATHEROSCLEROSIS behind almost all → predisposes to thrombosis, vasospasm, endothelial dysfunction. Microcirculation: small-vessel endothelium regulates flow abnormally. Uncommon: low blood oxygen content (respiratory); poor perfusion (hypotension, hypovolemia).
Major risk factorsAge · family history · abnormal lipids · smoking · hypertension · diabetes mellitus · obesity.
Probable risk factorsMale sex · HOMOCYSTEINE · high-sensitivity C-reactive protein.
Collateral circulationDevelops when plaque builds over YEARS — why slow occlusion is tolerated better than sudden.
Flow tracks demandMyocardial oxygen consumption and blood flow correspond NEARLY LINEARLY; METABOLIC SIGNALS are the principal determinants of delivery.
Coronary anatomyLEFT MAIN → left anterior descending (anterior interventricular) + CIRCUMFLEX. RIGHT CORONARY → marginal + posterior interventricular.
Frank–StarlingMore diastolic filling → more ejected. Force ∝ initial sarcomere length (preload). Maximal force at 2.6 micrometers, rarely exceeded in the normal heart.

L6 · Lipoproteins, Atherosclerosis & Plaque

TermWhat you need to know
Low-density lipoproteinCholesterol-rich → HIGHEST risk.
Very-low-density lipoproteinTriglyceride-rich → INCREASES risk.
High-density lipoproteinDECREASES risk — carries cholesterol BACK TO THE LIVER, away from plaque.
Familial hypercholesterolemiaCommon single-gene hyperlipidemia (classically taught as the most common). Defective LOW-DENSITY LIPOPROTEIN RECEPTOR on liver cells → liver cannot clear cholesterol.
HomocysteineAmino acid from METHIONINE → CYSTEINE. Atherogenic + prothrombotic: intimal thickening, elastic lamina disruption, smooth muscle hypertrophy, platelet accumulation, platelet-rich occlusive thrombus.
Plaque sequenceENDOTHELIAL INJURY (wall stress, toxins, inflammation, hyperlipidemia) → permeable endothelium, leukocytes recruited → low-density lipoprotein leaks in and is OXIDIZED → FOAM CELLS → mediators + growth factor → smooth muscle proliferation → LIPID CORE → collagen/fibrin CAP.
75%Occlusion at which blood flow is COMPROMISED.
Vulnerable plaque (slide 24, image only)LARGE lipid core · THIN fibrous cap · rich in MACROPHAGES · increased MMPs (matrix metalloproteinases) · POOR in smooth muscle · LOW-GRADE stenosis.
Stable vs vulnerableStable: thick cap, small core, many smooth muscle cells. Vulnerable: thin cap, large core, many macrophages. Smooth muscle BUILDS the cap; macrophages DIGEST it.
Why plaques ruptureComposition + mechanical stress. Trigger: SHEAR from high-velocity flow through a severe stenosis. VASA VASORUM capillaries hemorrhage → pressure builds inside the plaque.
Rupture consequencesExposed subendothelial proteins → platelet aggregation → THROMBUS; EMBOLI block smaller vessels downstream.

L6 · Angina & Acute Coronary Syndrome

TermWhat you need to know
Coronary syndromesCHRONIC: stable angina, ischemic cardiomyopathy. ACUTE: unstable angina, myocardial infarction. Classified by severity and onset.
Angina pectorisIntermittent ischemia NOT enough to kill cells; when demand rises; may cause pulmonary congestion.
Stable (typical)MOST COMMON. Fixed stenosis → ischemia only under increased WORKLOAD.
Prinzmetal (variant)VASOSPASM (cause unknown). Unpredictable; typically at REST, not with exertion.
Unstable (crescendo)May progress to acute ischemia → counted with the ACUTE coronary syndromes.
Acute coronary syndromeUnstable angina + myocardial infarction (hard to tell apart clinically). Pain longer than typical angina; PLAQUE RUPTURE + ACUTE THROMBOSIS.
Infarction mechanismProlonged/total loss of flow → NECROSIS or APOPTOSIS. Thrombus on a cracked plaque → platelet plug → clotting cascade → occlusion. Outcome depends on COLLATERALS, WORKLOAD, TIME.
Occlusion timelineImmediately: ATP depleted. Few minutes: cannot contract. AFTER 30 MINUTES: irreversible necrosis.
LocationNearly all in LEFT VENTRICLE. Left anterior descending 40–50% · right coronary 30–40% · left circumflex 15–20%.
Gross changesFirst several hours: hard to see by eye (slide: 6 h) · 18–24 h: paler · then yellow, soft, red vascular border · 1–2 weeks: necrotic tissue removed · by 6 weeks: fibrous scar.

L6 · Valve Disease

TermWhat you need to know
Stenosis vs regurgitationSTENOSIS = fails to OPEN → PRESSURE work, gradient across valve. REGURGITATION = fails to CLOSE → VOLUME work.
Stenosis factsHemodynamics affected at 50% closure; slow → compensatory HYPERTROPHY. Causes: RHEUMATIC scarring, aging CALCIFICATION.
Regurgitation factsAcute: infection or PAPILLARY MUSCLE RUPTURE. Important causes: rheumatic heart disease, infective endocarditis, degenerative valve changes, aortic root dilation.
Mitral stenosisDIASTOLIC left atrial > left ventricular gradient. Left atrial congestion/pressure ↑, pulmonary pressure ↑, stroke volume ↓ → pulmonary hypertension → right heart failure. Late: ATRIAL FIBRILLATION, atrial enlargement, ATRIAL CLOTS.
Mitral regurgitationSYSTOLIC backflow into atrium. HIGH AFTERLOAD INCREASES it. Atrium AND ventricle dilate + hypertrophy; severe → left heart failure.
Mitral valve prolapseBALLOONING into left atrium in systole. Usually silent; sometimes some regurgitation.
Aortic stenosisMost often AGE-RELATED CALCIFICATION; common with BICUSPID valve (slide: clinically apparent over 79). Systolic left ventricle–aortic gradient → LEFT VENTRICULAR HYPERTROPHY → ischemia and ANGINA → failure.
Aortic regurgitationDIASTOLIC leak back into left ventricle. AORTIC ROOT DILATION common (aging, connective tissue disease). Left ventricle hypertrophies + dilates; AORTIC DIASTOLIC PRESSURE FALLS (blood leaks back).
Timing ruleDIASTOLE: mitral stenosis, aortic regurgitation. SYSTOLE: mitral regurgitation, prolapse, aortic stenosis.

L6 · Infective, Myocardial & Pericardial

TermWhat you need to know
Rheumatic heart diseaseAfter GROUP A BETA-HEMOLYTIC STREPTOCOCCUS. IMMUNE attack by CROSS-REACTIVITY; HLA (human leukocyte antigen) predisposition. All layers → carditis. Valves: swelling, erosions, platelets + fibrin, then SCARRING and SHORTENING.
Infective endocarditisInvasion + colonization of endocardium; BLOODSTREAM INVASION is a prerequisite. VEGETATIONS = organisms in FIBRIN → dysfunction + EMBOLI. Commonest: Streptococcus, Staphylococcus aureus.
Subacute endocarditisInsidious; needs a PREEXISTING valve lesion. LESS VIRULENT organisms (typically Streptococcus) cannot attack a healthy endocardium. S. aureus is ACUTE, not subacute (the slide lists it here; Robbins pairs it with the acute form).
MyocarditisInflammation + leukocyte infiltration + necrosis. Microbes (most often viruses, classically COXSACKIEVIRUS), immune disease, physical agents. Left ventricular dysfunction, chambers sometimes dilated, edematous muscle, endocardium usually NORMAL.
Dilated cardiomyopathyAlso 'congested'. Dilation of one or both ventricles → failure. ALCOHOL · GENETICS · PREGNANCY · POST-VIRAL.
Hypertrophic cardiomyopathyThick, HYPERKINETIC muscle. OUTFLOW OBSTRUCTION + impaired DIASTOLIC FILLING.
Restrictive cardiomyopathyStiff, FIBROTIC, noncompliant (e.g. AMYLOIDOSIS) → restricted filling → low stroke volume → failure.
Pericardial effusion typesSEROUS transudate (heart failure, hypoproteinemia) · SEROSANGUINOUS (blunt trauma, heart surgery, cardiopulmonary resuscitation) · CHYLOUS (lymph obstruction) · BLOOD/hemopericardium (penetrating trauma).
TamponadeFluid, especially if it collects quickly, COMPRESSES chambers from outside → filling impaired. Life-threatening.
PericarditisACUTE: mostly idiopathic, mostly VIRAL. CHRONIC: ADHESIVE mediastinopericarditis (heart stuck to mediastinum → workload ↑) or CONSTRICTIVE (dense scarred sac = STIFF CAGE → impaired diastolic filling).
Not in the deckObjective m (blood pressure regulation) → see Lecture 7. Objective n (conduction system): no slide; only ischemia → abnormal rhythms, mitral stenosis → atrial fibrillation.

L7 · Vessel Anatomy & Function

TermWhat you need to know
Five componentsARTERIES high pressure, strong walls, fast flow → ARTERIOLES control release into capillaries (main resistance, 'small but mighty') → CAPILLARIES exchange → VENULES collect → VEINS return blood, RESERVOIR, low pressure, thin walls.
Three layersINTIMA: endothelium on basement membrane + thin matrix. MEDIA: elastin + smooth muscle 'like tree rings', expand in systole, recoil in diastole. ADVENTITIA: loose connective tissue, nerves, its own small arterioles in large vessels.
CapillariesNO MEDIA. ≈ red cell diameter. Large cross-section, LOW flow → easy exchange. Densest in MYOCARDIUM and BRAIN. Pericytes around them.
Capillary typesCONTINUOUS (least permeable; blood–brain barrier) · FENESTRATED (kidney glomeruli, small intestine) · SINUSOIDAL (leakiest; liver, marrow, spleen, endocrine).
FunctionsNutrients in · wastes out · hormones carried · HOMEOSTASIS of tissue fluid.
LoopsPULMONARY: right heart → lungs. SYSTEMIC: left heart → tissues → right heart. Artery = AWAY from heart, so pulmonary artery carries deoxygenated blood.
Veins holdAbout 66% of total blood volume.

L7 · Wall Injury, Vessel Size & Blood Pressure

TermWhat you need to know
Healthy endotheliumNONTHROMBOGENIC; modulates medial tone (resistance); METABOLIZES ANGIOTENSIN; regulates inflammation; controls smooth muscle growth.
Smooth muscle cellsPredominant media cell. Proliferate; make collagen, elastin, proteoglycans, growth factors, cytokines; constrict/dilate.
Neointimal hyperplasiaInjury → smooth muscle MIGRATES INTO INTIMA, proliferates, makes matrix; endothelium regrows with LESS NITRIC OXIDE; platelets activate; leukocytes recruited → thick intima, NARROW LUMEN. Same response to ANY injury.
The twofold problemThicker intima narrows the lumen AND lost nitric oxide (a vasodilator) lets it constrict.
Two mechanismsNARROWING (progressive: atherosclerosis; precipitous: thrombosis, embolism) or WEAKENING (dilation, rupture).
Size tends to predict diseaseTendencies, not rules (atherosclerosis also affects the aorta). LARGE elastic (aorta 2–3.5 cm) → ANEURYSM (elastic loss). MEDIUM muscular (coronary 3–4 mm, renal) → ATHEROSCLEROSIS. SMALL (≤2 mm) + ARTERIOLES (20–100 micrometers) → HYPERTENSION.
Blood pressure= CARDIAC OUTPUT × VASCULAR RESISTANCE. Resistance set at ARTERIOLES (constrictors vs dilators). Output = rate × stroke volume; volume set by SODIUM (water follows sodium).
Low pressure responseKidney RENIN (low afferent arteriolar pressure) → angiotensinogen → ANGIOTENSIN I → endothelial catabolism → ANGIOTENSIN II → smooth muscle tone ↑ + ALDOSTERONE ↑ (sodium resorption).
Hypertension risksAtherosclerosis, congestive heart failure, renal failure, CEREBRAL HEMORRHAGE, AORTIC DISSECTION.
Essential hypertension90–95%, idiopathic. Genetic + environmental. INSUFFICIENT RENAL SODIUM EXCRETION → volume ↑ → output ↑ → constriction → pressure ↑.
Secondary hypertensionRENOVASCULAR: renal artery stenosis → low afferent pressure → RENIN. PRIMARY HYPERALDOSTERONISM: a common cause.

L7 · Arteriosclerosis & Atherosclerosis

TermWhat you need to know
Arteriosclerosis'Hardening of the arteries': wall thickening + LOSS OF ELASTICITY. Four patterns below.
ArteriolosclerosisSmall arteries/arterioles; HYPERTENSION. HYALINE = protein-thickened glassy wall, narrow lumen. HYPERPLASTIC = ONION SKINNING (concentric smooth muscle).
Fibromuscular intimal hyperplasiaMuscular arteries; inflammation or mechanical injury; a healing response → IN-STENT RESTENOSIS; limits solid-organ transplants.
Mönckeberg medial sclerosisCALCIFICATION OF THE MEDIA of muscular arteries; usually NOT clinically significant.
Atherosclerosis'Gruel' + 'hardening'. MOST clinically relevant. Coronary, cerebral, peripheral disease; slide: about half of Western deaths (an older figure; roughly a third of United States deaths today).
Risk factorsHyperlipidemia · LIPOPROTEIN(a) (altered low-density lipoprotein, independent of total cholesterol) · smoking · hypertension · diabetes · METABOLIC SYNDROME · C-reactive protein · FAMILY HISTORY = strong risk, classically taught as the most important · age · men + postmenopausal women.
SequenceInjury → LOW-DENSITY LIPOPROTEIN accumulates → MONOCYTE adhesion → PLATELET adhesion → smooth muscle RECRUITED → proliferation, matrix, T cells → lipid → CALCIFICATION.
AtheromaIntimal plaque into the lumen: SOFT LIPID CORE + FIBROUS CAP. Stable → ischemia; unstable → rupture, thrombosis, embolism.
★ Peripheral arterial disease'Do know': stenosis → ischemia → CLAUDICATION when working muscle's demand rises.

L7 · Aneurysm & Dissection

TermWhat you need to know
Aneurysm vs dissectionANEURYSM = localized abnormal DILATION. DISSECTION = blood enters a wall defect and TUNNELS through the MEDIA.
ShapesTRUE saccular (focal bulge, 'berry') · TRUE fusiform (whole circumference) · FALSE (ruptured wall, hematoma held by extravascular tissue) · DISSECTION (intimal tear splits media).
Weakening ≠ ruptureAn aneurysm is a WEAK wall, not a ruptured one; rupture risk rises with SIZE (in lecture: under 4 cm rarely, over 5.5 cm very high).
PathogenesisPoor connective tissue (defective collagen; abnormal transforming growth factor signaling = MARFAN) · collagen degradation > synthesis (inflammation, proteases) · smooth muscle LOSS (ischemia, hypertension, TERTIARY SYPHILIS).
PredisposingAtherosclerosis · hypertension · smoking.
Abdominal aortic aneurysmATHEROSCLEROTIC; abdominal aorta + common iliac arteries.
Thoracic aortic aneurysmHYPERTENSION; also Marfan, inflammation.
Aortic dissectionLaminar planes of MEDIA SPLIT → blood channel in the wall. HYPERTENSION = major risk factor.
Cerebral saccular (berry)Thin/absent media; absent or fragmented internal elastic lamina. LACK OF ELASTIC LAMINA = main feature. Usually acquired.
Fusiform / mycoticFusiform: whole circumference (atherosclerosis). MYCOTIC: infected emboli from INFECTIVE ENDOCARDITIS (rare).

L7 · Other Arterial Disease & Veins

TermWhat you need to know
Fibromuscular dysplasiaFocal irregular thickening (hyperplasia + fibrosis of MEDIA and INTIMA) of medium/large muscular arteries → stenosis. RENAL arteries. 'STRING OF BEADS' on angiography; may dilate and rupture.
VasculitisVessel wall inflammation, mostly SMALL vessels. Mechanisms: IMMUNE-MEDIATED or DIRECT INFECTIOUS INVASION. Large: giant cell arteritis. Medium: polyarteritis nodosa, Kawasaki. Small: ANCA (anti-neutrophil cytoplasmic antibody) necrotizing; immune complex (lupus, rheumatoid arthritis). Said to go light.
Raynaud phenomenonEXAGGERATED VASOCONSTRICTION to COLD + STRESS, extremities. WHITE (spasm) → BLUE (anoxia) → RED (oxygenated blood returns).
Arteriovenous fistulaDirect artery–vein link BYPASSING CAPILLARIES: developmental, aneurysm rupturing into a vein, penetrating injury, inflammatory necrosis, surgical (hemodialysis access).
VeinsLarger lumen, THINNER MEDIA (capacitance), VALVES stop gravitational backflow.
Varicose veinsDilated, tortuous; VALVE INSUFFICIENCY; chronic high intraluminal pressure + weak wall. Superficial (saphenous), legs; also pelvis/rectum.
Esophageal varices / hemorrhoidsVarices: submucosal distal esophageal veins from CIRRHOSIS + PORTAL HYPERTENSION. Hemorrhoids: varicose venous plexus at the ANORECTAL junction.
Deep vein thrombosisDeep veins (femoral, popliteal, tibial); STASIS in a dilated vein. THIRD most common cardiovascular cause of death.
Deep vein thrombosis risksReduced flow (IMMOBILITY) · raised venous pressure · mechanical injury · raised viscosity (dehydration, thrombocytosis) · anatomy · hypercoagulable (cancer, sepsis, lupus, ORAL ESTROGEN).
Virchow triadVESSEL WALL DAMAGE · ABNORMAL BLOOD FLOW (turbulence or stasis) · HYPERCOAGULABILITY.
Clot fateNeutrophils + macrophages infiltrate fibrin; COLLAGEN replaces fibrin over weeks → less flow. Dislodges → EMBOLUS → PULMONARY ARTERY = pulmonary embolus.

L8 · Immunity Basics & Blood Cells

TermWhat you need to know
Immunity: 3 functionsDEFENSE (resistance to invaders) · SURVEILLANCE (of self, for mutant or cancerous cells) · HOMEOSTASIS (removing cellular debris).
Memory & specificityMemory = faster, stronger adaptive response on RE-EXPOSURE. B- and T-cell receptors recognize particular EPITOPES; innate receptors recognize patterns shared by groups of organisms.
Active vs passiveACTIVE: the body's own response after antigen exposure (natural = met naturally; artificial = VACCINATION). PASSIVE: PREFORMED antibodies transferred; immediate protection that declines.
Passive examplesNatural: maternal IgG through the PLACENTA, IgA in BREAST MILK. Artificial: tetanus and rabies immune globulin.
Innate immunityActs WITHOUT prior sensitization: skin and mucosal barriers, phagocytes, complement, interferons. Natural killer cells ≈ 5–15% of circulating lymphocytes.
GranulocytesNEUTROPHIL: phagocytosis, first responders, most numerous. EOSINOPHIL: allergy and parasites. BASOPHIL: like tissue mast cells (★ 'Baso B blood', mast cells in tissue).
Monocyte → macrophageMonocytes enter tissues during inflammation and become macrophages (tissue macrophage = HISTIOCYTE); they remove material and coordinate inflammation.
LymphocytesB: humoral, matures in BONE MARROW, becomes the plasma cell. T: cellular, matures in the THYMUS (★ 'T cells, thymus'). Natural killer: needs NO specific antigen; kills tumor and infected cells.
MarkersT: CD3 (CD4 or CD8). B: CD19, CD20; surface immunoglobulin LOST as a plasma cell. Natural killer: CD56, CD16.
PhagocytosisAdhere → pseudopods engulf (PHAGOSOME) → fuse with lysosome (PHAGOLYSOSOME) → acid hydrolases digest → residual body → EXOCYTOSIS.
Lymph flowNo pump: SKELETAL MUSCLE movement, THORACIC pressure changes in breathing, pulsing ARTERIES; valves keep it one-way.

L8 · B Cells & Antibodies

TermWhat you need to know
B cell → plasma cellAntigen-INDEPENDENT phase: surface IgM. Antigen-DEPENDENT phase (started by antigen exposure): becomes a PLASMA CELL secreting specific antibody. Antigen SELECTS the matching B cell → clonal expansion → plasma + memory cells.
Primary responseAfter FIRST exposure; develops over days; IgM rises first; memory cells form.
Secondary responseAfter RE-EXPOSURE; memory cells → FASTER, STRONGER (★); class-switched antibody, often IgG, higher and longer. ★ High IgM = first exposure; low IgM + high IgG = earlier exposure.
Antibody unit2 HEAVY + 2 LIGHT chains (light = KAPPA or LAMBDA). Heavy + light VARIABLE regions = antigen-binding site. Heavy-chain CONSTANT region decides the CLASS.
Fab vs FcFab = antigen-binding arms. Fc = constant stem → EFFECTOR functions (complement-binding site on CH2). Papain cuts IgG into 2 Fab + Fc.
IgM5–10%. PENTAMER (J chain) when secreted. Often FIRST in a new response; AGGLUTINATION; efficient classical complement.
IgG75–80%, the largest share. Monomer, 4 subclasses. CROSSES THE PLACENTA (★ how maternal immunity reaches the baby); prominent in secondary responses.
IgA · IgD · IgEIgA 10–15%: secretory DIMER (saliva, tears, colostrum), blocks microbial attachment. IgD <1%: B-cell receptor with IgM. IgE <1%: on MAST CELLS and BASOPHILS → allergy, anaphylaxis, parasites.
Antibody functionsAGGLUTINATION (clumps cells) · NEUTRALIZATION (blocks without destroying ★) · LYSIS (with complement) · PRECIPITATION (cross-links soluble antigen) · OPSONIZATION (coats for phagocytes).
ABOO red cells carry neither A nor B → O is the universal red-cell donor (★); AB recipients have neither antibody → take O, A, B, AB.

L8 · T Cells & Hypersensitivity

TermWhat you need to know
★ CD4 vs CD8'Four letters in HELP': CD4 = HELPER, reads MHC (major histocompatibility complex) CLASS II. CD8 = CYTOTOXIC, reads CLASS I.
Helper T cellCOORDINATES cellular and humoral responses by cytokines and contact; supports B-cell antibody production; IFN-γ (interferon gamma) activates macrophages.
Cytotoxic T cellKills virus-infected, tumor and transplanted cells: PERFORIN + GRANZYMES → target-cell APOPTOSIS.
Regulatory T cellLIMITS immune activation, maintains SELF-TOLERANCE; many are CD4 expressing FOXP3.
ADCCAntibody-dependent cellular cytotoxicity: the natural killer cell's CD16 binds the Fc of IgG coating a target.
HypersensitivityHumoral or cellular immune reactions that INJURE the body. Numbered by MECHANISM, not severity (★).
Type IIgE fixed on MAST CELLS/basophils after a sensitizing exposure; re-exposure → HISTAMINE release. Local allergy or ANAPHYLAXIS (bronchospasm, laryngeal edema, hypotension).
Type IIIgG or IgM binds antigen ON cells or tissue → phagocytosis, complement, ADCC; can STIMULATE or BLOCK receptors. ABO incompatibility, anti-glomerular basement membrane disease.
Type IIIAntigen–antibody COMPLEXES deposit in tissue or vessel walls. Arthus (local), serum sickness (systemic), LUPUS.
Type IVSensitized CD4 or CD8 T CELLS; delayed 24–72 h; granulomas. Contact dermatitis, tuberculosis reactions, transplant rejection.

L8 · Complement, Immunodeficiency & Age

TermWhat you need to know
ComplementProteins made mostly by the LIVER, circulating as INACTIVE precursors; activation = a regulated CASCADE.
3 pathways (★)CLASSICAL: C1 binds antigen-bound IgM or IgG. LECTIN: mannose-binding lectin binds microbial carbohydrate. ALTERNATIVE: C3 on permissive surfaces (factor B, factor D, properdin). All CONVERGE ON C3.
3 outcomesOPSONIZATION (C3b coat) · INFLAMMATION (C3a, C4a, C5a: vasodilation, attraction of phagocytes) · MEMBRANE ATTACK COMPLEX (C5b + C6–C9 pore → lysis). ★ Lysis is only ONE outcome.
Autoimmunity (deck)No slide of its own: regulatory T cells keep self-tolerance; anti-self antibody can destroy or stimulate/block (type II); lupus is type III; autoantibodies rise with age.
Primary immunodeficiencyINTRINSIC, often GENETIC. X-linked agammaglobulinemia: no B-cell maturation → recurrent PYOGENIC infections. DiGeorge: thymic/T-cell development. Severe combined: T AND B.
Secondary immunodeficiencyFrom disease, medications, malignancy or poor nutrition.
AgeNeonates: protected by maternal IgG and milk IgA, which wane. Older adults: weaker responses to NEW antigens; more autoantibodies.

L9 · Respiratory Failure, Pulmonary Hypertension & Cancer

TermWhat you need to know
Hypoxemia vs hypoxiaHypoxemia = low BLOOD oxygen (PaO2, arterial oxygen tension; saturation). Hypoxia = low TISSUE oxygenation.
Acute respiratory failureOn room air: PaO2 < 60 mmHg · PaCO2 (arterial carbon dioxide tension) > 50 mmHg · pH < 7.30.
Hypoxic failureLow oxygen, NORMAL or LOW carbon dioxide: V/Q (ventilation/perfusion) mismatch · SHUNT · decreased diffusion · alveolar hypoventilation · altitude.
Hypercapnic failureCarbon dioxide not removed: low ventilation or rate · cannot signal (Guillain-Barré, cord injury) · DEAD SPACE (pulmonary embolism, low output) · more carbon dioxide made (fever, burns) · cannot sense it (drugs).
★ Dead space vs shuntDead space = ventilation without perfusion. Shunt = perfusion without ventilation.
Pulmonary circulationHIGH FLOW, LOW PRESSURE: 22/8–25/8 mmHg, mean 15. Pulmonary arteries carry DEOXYGENATED blood (★ names = direction, not oxygen).
Pulmonary hypertensionMean pulmonary arterial pressure AT REST > 20 mmHg (normal mean ≈ 15).
Routes to itMore FLOW (left-to-right shunt, polycythemia) · more RESISTANCE (hypoxic vasoconstriction, EMBOLISM, fibrosis) · higher LEFT ATRIAL pressure (mitral stenosis).
Vessel changesMEDIA thickens (more muscle), INTIMA fibroses.
Lung cancersSQUAMOUS 20–30%, central, sputum cytology. ADENO 35–40% (largest), peripheral. LARGE CELL 5–10%, peripheral. SMALL CELL 15–20%, central, doubles in ~33 days, PARANEOPLASTIC.

L9 · Obstructive Disease & Asthma

TermWhat you need to know
Obstructive diseaseIncreased airflow RESISTANCE: in the WALL (asthma, bronchitis) · LOST PARENCHYMA (emphysema) · in the LUMEN (bronchiectasis, cystic fibrosis, foreign body).
Test patternLow FEV1/FVC (forced expiratory volume in 1 second / forced vital capacity) = airflow limitation · high RESIDUAL VOLUME = incomplete emptying · low DLCO (diffusing capacity for carbon monoxide) = a separate gas-transfer question.
AsthmaREVERSIBLE obstruction + airway inflammation + HYPER-RESPONSIVENESS.
Allergic (extrinsic)IgE on MAST CELLS → histamine, LEUKOTRIENES (slow-reacting substances of anaphylaxis), prostaglandins, bradykinins, eosinophil chemotactic factor, serotonin.
Non-allergic (intrinsic)Exercise, stress, irritants, aspirin; NEGATIVE skin tests, NORMAL IgE; middle age; worse prognosis.
Asthma airwayEpithelium DENUDED → goblet cells · COLLAGEN under basement membrane · edema · mucus plugs · VAGAL → mucus + bronchoconstriction · REMODELING.
Acute bronchitisInflamed trachea/bronchi, mostly VIRAL; more mucus, lost cilia; lasting HYPERIRRITABILITY explains the lingering cough.
Chronic bronchitis (type B)Productive cough > 3 months a year for 2+ years; smoking 90%; gland + GOBLET hypertrophy; cilia → SQUAMOUS; plugs → V/Q mismatch. BLUE BLOATER = cyanosis + right-heart edema.
Emphysema (type A)Alveolar wall DESTRUCTION WITHOUT FIBROSIS. PROTEASES from neutrophils/macrophages; smoking inactivates ALPHA-1 ANTITRYPSIN. Lost RADIAL TRACTION → more resistance, less airflow; air trapped → BULLAE. PINK PUFFER.
Emphysema typesCENTRIACINAR: respiratory bronchioles (with chronic bronchitis). PANACINAR: alveoli. PARASEPTAL: peripheral lobules.
BronchiectasisWall DESTRUCTION → DILATED bronchi; congenital (50% related to cystic fibrosis) or acquired; children at risk (soft bronchi). Dilations = infection POCKETS → foul purulent sputum. Shapes: cylindrical, saccular, fusiform.
Cor pulmonaleHypoxia → pulmonary VASOCONSTRICTION → pulmonary hypertension → RIGHT VENTRICULAR DILATION → right heart failure.

L9 · Restrictive Disease & Acute Respiratory Distress Syndrome

TermWhat you need to know
Restrictive = expansionDECREASED EXPANSION from parenchyma, pleura, chest wall or neuromuscular disease. LOW TOTAL LUNG CAPACITY confirms it (low FVC alone does not).
Interstitial lung diseaseStarts with INJURY to alveolar epithelium or capillary endothelium → immune reaction → thick interstitium, COLLAGEN.
3 alveolar patternsINFLAMMATION (early, REVERSIBLE) → FIBROSIS (fibroblasts, collagen) → DESTRUCTION (end stage: STIFF, NONCOMPLIANT lungs).
SarcoidosisALVEOLAR MACROPHAGES activated by an unknown trigger; NONCASEATING epithelioid GRANULOMAS (lymph nodes, lung); ASTEROID BODIES; abnormal T cells.
Hypersensitivity pneumonitisInhaled ORGANIC agents (birds, fungi, wheat weevil); antibodies → TYPE III immune complexes (cell-mediated immunity also contributes); nonsmokers. 'Extrinsic allergic alveolitis'.
PneumoconiosisInhaled INORGANIC dust (coal, silica, asbestos); macrophages cannot clear it → FIBROSIS. Smoking depresses ciliary clearance.
ARDS (acute respiratory distress syndrome)ATELECTATIC disorder. Alveolar-capillary membrane DAMAGE → LEAKY capillaries → protein-rich NONCARDIOGENIC edema; complement + neutrophil sequestration.
ARDS: 3 processesNoncardiogenic EDEMA (leaky capillaries) · ATELECTASIS (no SURFACTANT) · HYALINE MEMBRANES (protein deposits).
Pulmonary edema (gathered)Starling: hydrostatic OUT vs oncotic IN. More capillary pressure or less oncotic pressure → more filtration. Leaky capillaries → noncardiogenic edema.

L9 · Pleura, Sleep Apnea & Pneumonia

TermWhat you need to know
Primary pneumothoraxTALL, THIN MEN 20–40; SUBPLEURAL BLEBS at the apices rupture; smoking raises risk.
Secondary pneumothoraxComplication of lung disease: asthma, emphysema, cystic fibrosis, pneumonia, tuberculosis.
Tension pneumothoraxPneumothorax that TRAPS AIR and builds pressure (penetrating or nonpenetrating injury); air ENTERS but cannot LEAVE → lung collapses, mediastinum shifts AWAY → less VENOUS RETURN and CARDIAC OUTPUT.
Pleural effusion causesRaised HYDROSTATIC pressure (heart failure) · lowered ONCOTIC pressure (nephrotic syndrome, cirrhosis) · lowered pleural pressure (lung collapse). Normal 5–15 mL.
TransudateProtein ratio < 0.5 · LDH (lactate dehydrogenase) ratio < 0.6 · specific gravity < 1.016. PRESSURE problem: heart failure, cirrhosis, nephrotic syndrome.
ExudateProtein ratio > 0.5 or LDH ratio > 0.6 (ONE criterion is enough). PERMEABILITY or LYMPHATIC problem: cancer, infection, PULMONARY EMBOLISM, sarcoidosis.
ChylothoraxCHYLE leaking from the THORACIC DUCT (trauma, lymphoma).
Obstructive sleep apnea≥ 5 events/hour; collapsible PHARYNX closes. APNEA: no airflow ≥ 10 s WITH effort. HYPOPNEA: reduced flow + desaturation or arousal. No flow + NO effort = CENTRAL.
Pneumonia sourcesASPIRATION (gross aspiration → ANAEROBES, abscess) · inhalation (virus, Mycoplasma) · BLOOD-BORNE (right-sided endocarditis, intravenous drug use).
Community vs hospitalCommunity: at home, or hospitalized < 48 h. Hospital: early (≤ 4 days) susceptible bacteria; LATE = MULTIDRUG-RESISTANT.
Pulmonary embolism (gathered)Raises DEAD SPACE (hypercapnia) · causes pulmonary hypertension by OBSTRUCTION · causes ARDS and acute respiratory failure · EXUDATIVE effusion.

L10 · ★ Neutropenia grades (slide 9)

GradeAbsolute neutrophil count
Mild1,000–1,500 cells/µL
Moderate500–1,000 cells/µL
Severe< 500 cells/µL
Agranulocytosis< 200 cells/µL
★ The only lab values the lecturer said to memorize.
Memory aid

“Fifteen, ten, five, two” — hundreds per microliter, counting down.

15 below 1,500 = mild10 below 1,000 = moderate5 below 500 = severe2 below 200 = agranulocytosis

L10 · ★ Bone marrow neoplasms (slide 18)

GroupProcessMembers / note
Myelodysplastic (MDS)Ineffective hematopoiesis with cytopenias and DYSPLASIACan progress to AML
Acute myeloid leukemia (AML)Impaired DIFFERENTIATION + abnormal BLAST proliferationDistinct from MDS
Myeloproliferative (MPN)CLONAL PROLIFERATION of myeloid cellsCML · polycythemia vera · essential thrombocythemia · primary myelofibrosis (can cause cytopenias)
Memory aid

Dys-, blasts, pro-: made badly, never grow up, made too many.

Dys myelodysplasticBlasts acute myeloid leukemiaPro myeloproliferative

Where it breaks: MPN members by first letters: “Can People Eat Pie?” = CML, Polycythemia vera, Essential thrombocythemia, Primary myelofibrosis.

L10 · ★ Lymphoid neoplasms (slides 23, 28)

Cell of originNeoplasmWord
Precursor B or T cellsAcute lymphoblastic leukemia/lymphomaPRECURSOR
Mature B cellsChronic lymphocytic leukemia / small lymphocytic lymphoma and other B-cell lymphomasMATURE
Mature T and NK cellsDistinct T-cell and NK-cell neoplasmsMATURE
Germinal-center B cellsClassic Hodgkin lymphoma—
Differentiated antibody-producing B-lineage cellsPlasma-cell myelomaDIFFERENTIATED
Memory aid

A-C-M runs young to old: Acute (precursor) → Chronic (mature) → Myeloma (differentiated).

A acute lymphoblastic — precursorC chronic lymphocytic — matureM myeloma — differentiated

Where it breaks: Hodgkin lymphoma (germinal-center B cells) and the mature T/NK neoplasms sit outside the chain.

L10 · Anemia by mean cell volume (slide 33)

GroupMCVCauses on the slide
Microcytic< 80 fLIron deficiency · thalassemia · inflammation (some cases) · sideroblastic anemia
Normocytic80–100 fLBlood loss or hemolysis · inflammation or renal disease · marrow failure or infiltration · EARLY iron deficiency
Macrocytic> 100 fLMegaloblastic: B12 or folate deficiency · Nonmegaloblastic: liver disease, alcohol, drugs, reticulocytosis
Marrow response (reticulocytes / RPI): LOW = reduced production, or an early/blunted response to loss or destruction · INCREASED = blood loss, hemolysis or recovery; a rise usually takes several days.
Memory aid

Micro “TICS”: Thalassemia, Iron deficiency, Chronic inflammation, Sideroblastic.

T thalassemiaI iron deficiencyC inflammation (some cases)S sideroblastic

Where it breaks: The C is a memory addition (“chronic”); the slide says inflammation (some cases).

L10 · Erythrocytosis (slide 41)

TypeRed-cell massMechanism
RelativeNot increasedReduced PLASMA volume (dehydration)
Absolute — polycythemia veraIncreasedClonal myeloproliferative neoplasm
Absolute — secondaryIncreasedErythropoietic response to hypoxia, increased erythropoietin or other stimuli
Memory aid

Water, clone, or air: plasma lost, a clone, or hypoxia.

Water relativeClone polycythemia veraAir secondary (hypoxia)

Where it breaks: Secondary also includes increased erythropoietin and other stimuli.

L10 · ★ Coagulation tests and disorders (slides 43–46)

ItemFactors / cause
PT (prothrombin time)Extrinsic VII + common
aPTT (activated partial thromboplastin time)Intrinsic XII, XI, IX, VIII + common
Common pathwayX, V, II, I
Hemophilia AFactor VIII deficiency
Hemophilia BFactor IX deficiency
Von Willebrand diseaseVWF supports platelet adhesion and carries/stabilizes factor VIII
Factor V Leiden (thrombophilia)Genetic mutation
Antiphospholipid syndrome (thrombophilia)Autoimmune response
Memory aid

Common pathway = “10, 5, 2, 1” — like a countdown to the clot. PT has the one short factor (VII); PTT the long list (12, 11, 9, 8).

A→8 hemophilia A = VIIIB→9 hemophilia B = IX

Where it breaks: Covers the common pathway, the two tests and the hemophilias only; von Willebrand disease, factor V Leiden and antiphospholipid syndrome are not in the aid.

L10 · Blood, White Cells & Neoplasia

TermWhat you need to know
Blood55% PLASMA, 45% formed elements; plasma 90–92% water; SERUM = fluid left after clotting. Adult hematopoiesis: AXIAL skeleton + PROXIMAL humerus and femur.
LineageMYELOID progenitor → erythroid precursors, MEGAKARYOCYTES (platelets), granulocytes, monocytes (→ MACROPHAGES). LYMPHOID → B, T, NK cells.
Normal differentialNeutrophils 40–60% · lymphocytes 20–40% · monocytes 2–8% · eosinophils 1–4% · basophils 0.5–1%.
Relative vs absoluteAbsolute = WBC count × relative fraction. A fall in one type can ARTIFICIALLY raise another's percentage.
NeutrophilsFirst responders; with macrophages, the PHAGOCYTIC leukocytes. Neutrophilia → acute BACTERIAL inflammation. Severe neutropenia → serious infection risk.
BandsBANDEMIA = more immature neutrophils (LEFT SHIFT). Historical SIRS: > 10% bands. SEPSIS-3 = infection-associated, life-threatening ORGAN DYSFUNCTION.
Monocytes ↑Chronic myelomonocytic leukemia · autoimmune (sometimes) · chronic infection (CMV, tuberculosis).
Eosinophils ↑ALLERGY (esp. asthma) · PARASITE · DRUG effect; rarely neoplastic/autoimmune.
Basophils ↑Bind IgE; parasites and allergy; few on a CBC → consider MALIGNANCY.
V(D)JB cells rearrange immunoglobulin genes in the MARROW: heavy chains V, D, J; LIGHT chains V and J. Germinal centers: SOMATIC HYPERMUTATION → affinity maturation.
ClonalityClone = descended from ONE progenitor. PCR finds a dominant receptor-gene rearrangement, but REACTIVE or premalignant cells can be clonal too → not proof of malignancy.
Acute leukemia★ MATURATION ARREST (transcription-factor mutations) + growth factor–independent proliferation → LYMPHOBLASTS / MYELOBLASTS.
Leukemia countsPeripheral WBC LOW, NORMAL or HIGH; marrow involvement suppresses normal production → CYTOPENIAS. Hyperleukocytosis = very high count; LEUKOSTASIS = impaired microcirculation + organ injury (LUNGS, BRAIN).
Risk factorsChemical, viral, radiation MUTAGENS (effects of chemotherapy or immunodeficiency disorders). Result: too few normal WBC, RBC, platelets.
Lineage figureRed-cell line → POLYCYTHEMIA VERA / erythroid leukemia; megakaryocyte → ESSENTIAL THROMBOCYTHEMIA / megakaryocytic leukemia.
Multiple myelomaCLONAL PLASMA CELLS in marrow. Proteins + infiltration → RENAL injury, ANEMIA, impaired IMMUNITY; altered bone remodeling → OSTEOLYTIC lesions + HYPERCALCEMIA. Active = plasma-cell neoplasm + a MYELOMA-DEFINING EVENT (bone lesions not required).

L10 · Red Cells, Coagulation & Platelets

TermWhat you need to know
IndicesMCV = average VOLUME · MCH = average hemoglobin MASS per cell · MCHC = hemoglobin CONCENTRATION in packed cells.
Morphology cluesSIZE · HEMOGLOBINIZATION (color: normo-/HYPOCHROMIC) · SHAPE.
Small vs bigMicrocytic hypochromic = HEMOGLOBIN SYNTHESIS disorder. Macrocytic = impaired ERYTHROID PRECURSOR MATURATION. Normocytic: SHAPE is the clue.
AnemiaReduces OXYGEN-CARRYING capacity; defined by HEMOGLOBIN below the cutoff for age, sex, pregnancy. WHO 2024 (15–65): < 13 g/dL men, < 12 g/dL nonpregnant women. Read Hb/Hct against PLASMA volume.
HemolysisSurvival < ~120 DAYS; breakdown products ↑; EPO and reticulocytes ↑ if marrow compensates; blunted by marrow disease, nutrient deficiency, RENAL disease, infection.
ExtravascularOld red cells die in MACROPHAGES (spleen, liver, marrow) — age-dependent SURFACE PROTEIN changes. Most hemolytic anemias: premature destruction in PHAGOCYTES = EXTRAVASCULAR.
Hereditary spherocytosisLose lipid MEMBRANE → RIGID spherocytes → TRAPPED in spleen → eaten by splenic macrophages.
Diminished erythropoiesisMegaloblastic · vitamin B12 deficiency · IRON deficiency · APLASTIC anemia.
Initiation★ TISSUE FACTOR–VIIa activates IX and X; external bleeding NOT required.
Key reactions★ IXa + VIIIa → Xa · Xa + Va → THROMBIN (from prothrombin) · thrombin: fibrinogen → fibrin · XIIIa crosslinks. COFACTORS = VIIIa and Va; Ca²⁺ + phospholipid assemble complexes.
Regulation vs fibrinolysisLIMIT coagulation: ANTITHROMBIN + activated PROTEIN C with PROTEIN S. Fibrinolysis (separate): plasminogen → PLASMIN degrades fibrin.
ThrombocytopeniaReduced marrow production · IMMUNE destruction (ITP) · drug reactions (immune HIT).
ThrombocytosisREACTIVE: inflammation, infection, IRON deficiency · PRIMARY: clonal marrow disorder.
Qualitative plateletInherited: ADHESION, AGGREGATION, SECRETION · Acquired: external factors, systemic disease.
HITImmune heparin-induced thrombocytopenia: platelet ACTIVATION → THROMBOSIS despite a falling count.